多巴胺转运蛋白显像剂<sup>131</sup>I-FP-β-CIT的临床前药理研究

陈正平; 周翔; 丁时踽; 林岩松; 唐军; 王峰; 吴春英; 纪书仁; 陆春雄; 方平

doi:null

您当前的位置：

首页 >

文章列表页 >

多巴胺转运蛋白显像剂¹³¹I-FP-β-CIT的临床前药理研究

更新时间：2021-03-12

- 多巴胺转运蛋白显像剂¹³¹I-FP-β-CIT的临床前药理研究
- Preclinical pharmacological studies of ¹³¹I-FP-β-CIT as dopamine transporter imaging agent
- 核技术 2003年第11期
- 作者机构：
  
  1. 江苏省原子医学研究所核医学国家重点实验室
  2. 苏州大学附属第二医院核医学科
  3. 江苏省原子医学研究所核医学国家重点实验室,无锡,214063
  4. ,苏州,215004
- 作者简介：
- 基金信息：
  
  (No.ZX069)
- DOI：
  中图分类号： R96
- 纸质出版日期：2003-11-01
- 稿件说明：
移动端阅览
[1]陈正平,周翔,丁时踽,林岩松,唐军,王峰,吴春英,纪书仁,陆春雄,方平.多巴胺转运蛋白显像剂~(131)I-FP-β-CIT的临床前药理研究[J].核技术,2003(11):858-862.

CHEN Zhengping ZHOU Xiang DING Shiyu LIN Yansong TANG Jun WANG Feng WUChunying JI Shuren LU Chunxiong FANG Ping. Preclinical pharmacological studies of ¹³¹I-FP-β-CIT as dopamine transporter imaging agent[J]. Nuclear techniques, 2003, (11): 858-862.
[1]陈正平,周翔,丁时踽,林岩松,唐军,王峰,吴春英,纪书仁,陆春雄,方平.多巴胺转运蛋白显像剂~(131)I-FP-β-CIT的临床前药理研究[J].核技术,2003(11):858-862. DOI：

CHEN Zhengping ZHOU Xiang DING Shiyu LIN Yansong TANG Jun WANG Feng WUChunying JI Shuren LU Chunxiong FANG Ping. Preclinical pharmacological studies of ¹³¹I-FP-β-CIT as dopamine transporter imaging agent[J]. Nuclear techniques, 2003, (11): 858-862. DOI：

摘要

报道了用自制的131I-FP-β-CIT（N-（3’-氟丙基）-2β-羰甲氧基-3β-（4’-碘苯基）托烷）测定分配比

进行大鼠体内及脑内分布、兔血药清除动力学、大鼠脑放射自显影、猴显像和异常毒性等实验。结果显示:131I-FP-β-CIT脂溶性大

在pH为7.0和7.4时的分配比分别为15和28;药物能迅速进脑

并有较好的滞留（2 min时脑摄取为0.78％ID

2 h时为0.59％ID）;脑内药物在纹状体中浓聚

1h时纹状体与小脑、额叶、海马的比值分别为5.23、2.15和3.10;纹状体的摄取能被β-CFT阻滞

表明药物与多巴胺转运蛋白（DAT）结合的亲和性和特异性较好;药物在兔血中清除迅速

血药浓度降至一半所需时间约为2 min;放射自显影显示出药物在纹状体区域的放射性浓聚

左右纹状体基本对称

纹状体与顶叶的比值为2.7;正常猴显像表明在注药后2 h时纹状体与颞叶、小脑的比值分别为5.4和3.0;异常毒性实验结果显示小鼠所耐受的剂量为人的750倍

表明药物非常安全。以上结果表明131I-FP-β-CIT与DAT有很好的亲和性与特异性

其体内性质适合显像

具有良好的临床应用前景。

Abstract

The 13I-FP-β-CIT (2β-carbomethoxy-3β-(4-iodophenyl)tropane) was prepared by ourselves. Its partition coefficients were determined. Kinetics of blood clearance in rabbits

biodistribution in rats brains

toxicity test in mice as well as autoradiography in rat’s brain

SPECT imaging in normal monkey’s brain were studied. The partition coefficients were 15 and 28 at pH 7.0 and 7.4 respectively. The brain uptake in rats was rapid (0.78

0.59 %ID/organ at 2 min

2 h after injection respectively)

the ratios of striatum/cerebellum

striatum /frontal cortex and striatum / hippocampus were 5.2

2.2 and 3.1 at 1 h in rat’s brain. The uptake in striatum could be blocked by p-CFT

suggesting that 131I-FP-β-ClT binds to DAT specifically. The compound was rapidly cleared from rabbits’ blood

taking only 2 min to reduce to half of the original concentration. The ratio of striatum/occipital cortex is 2.7 in autoradiography of rat’s brain. l31l-FP-β-CIT concentrated in striatum in SPECT imaging in normal monkey. The ratio of striatum /cerebellum and striatum /occipital cortex were 5.4 and 6.0 respectively at 2 h. The test of toxicity showed that the dose received by mice was 750 times by human

proving the agent was safe. These results suggest that the compound is a good SPECT imaging agent for DAT.

关键词

Keywords

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

针灸对帕金森小鼠模型运动机能调节的分子机制研究

吗啡戒断大鼠脑多巴胺转运蛋白及D2受体的研究

⁹⁹TC^m-TRODAT-1 SPECT脑多巴胺转运体显像在帕金森病病情监测中的价值

多巴胺转运蛋白显像剂FP-β-CIT的合成及碘标记

用¹²⁵I-β-CIT与¹²⁵I-IBZM体内放射自显影研究MPTP致帕金森病小鼠中枢多巴胺转运蛋白与受体变化

多巴胺转运蛋白显像剂131I-FP-β-CIT的临床前药理研究

Preclinical pharmacological studies of 131I-FP-β-CIT as dopamine transporter imaging agent

DOI：

摘要

Abstract

关键词

Keywords

references

多巴胺转运蛋白显像剂¹³¹I-FP-β-CIT的临床前药理研究

Preclinical pharmacological studies of ¹³¹I-FP-β-CIT as dopamine transporter imaging agent